Imvaria San Francisco
Berkeley, US · Founded 2019 · 8 employees on LinkedIn · 3 known investors
Find your way into Imvaria San Francisco
1,168 people in our graph share verified history with the Imvaria San Francisco team — schools, employers, funds. One of them is your warm intro.
IMVARIA develops AI-driven software-as-medical-device solutions that analyze medical imaging and data to provide non-invasive diagnostic assessments for lung diseases, including idiopathic pulmonary fibrosis and interstitial lung disease. The company's FDA-authorized tools serve pulmonologists and other clinicians to reduce the need for invasive biopsy testing.
Founders & leadership
Imvaria San Francisco was founded in 2019 by Joshua Reicher and Michael Muelly.

Investors · 3
Competitors · 4
by search overlapCompanies competing with Imvaria San Francisco for the same Google search keywords, organic and paid, via search-intersection analysis.
Frequently asked questions
- What does Imvaria San Francisco do?
- IMVARIA develops AI-driven software-as-medical-device solutions that analyze medical imaging and data to provide non-invasive diagnostic assessments for lung diseases, including idiopathic pulmonary fibrosis and interstitial lung disease. The company's FDA-authorized tools serve pulmonologists and other clinicians to reduce the need for invasive biopsy testing.
- Who founded Imvaria San Francisco?
- Imvaria San Francisco was founded by Joshua Reicher, Michael Muelly in 2019.
- Who are Imvaria San Francisco's investors?
- Imvaria San Francisco's investors include Creative Ventures, InHealth Ventures, Meridian Street Capital.
- Where is Imvaria San Francisco headquartered?
- Imvaria San Francisco is headquartered in Berkeley, US.





